Kamenov Zdravko, et al.
Maturitas, 2017
Abstract
Objective
The primary objectives were to compare the efficacy of extracts of the plant Tribulus terrestris (TT; marketed as Tribestan), in comparison with placebo, for the treatment of men with erectile dysfunction (ED) and with or without hypoactive sexual desire disorder (HSDD), as well as to monitor the safety profile of the drug. The secondary objective was to evaluate the level of lipids in blood during treatment. Participants and
Design
Phase IV, prospective, randomized, double-blind, placebo-controlled clinical trial in parallel groups. This study included 180 males aged between 18 and 65 years with mild or moderate ED and with or without HSDD: 90 were randomized to TT and 90 to placebo. Patients with ED and hypertension, diabetes mellitus, and metabolic syndrome were included in the study. In the trial, an herbal medicine intervention of Bulgarian origin was used (Tribestan®, Sopharma AD). Each Tribestan film-coated tablet contains the active substance Tribulus terrestris, herba extractum siccum (35-45:1) 250mg which is standardized to furostanol saponins (not less than 112.5mg). Each patient received orally 3×2 film-coated tablets daily after meals, during the 12-week treatment period. At the end of each month, participants' sexual function, including ED, was assessed by International Index of Erectile Function (IIEF) Questionnaire and Global Efficacy Question (GEQ). Several biochemical parameters were also determined. The primary outcome measure was the change in IIEF score after 12 weeks of treatment. Complete randomization (random sorting using maximum allowable% deviation) with an equal number of patients in each sequence was used. This randomization algorithm has the restriction that unequal treatment allocation is not allowed; that is, all groups must have the same target sample size. Patients, investigational staff, and data collectors were blinded to treatment. All outcome assessors were also blinded to group allocation.
Results
86 patients in each group completed the study. The IIEF score improved significantly in the TT group compared with the placebo group (Р<0.0001). For intention-to-treat (ITT) there was a statistically significant difference in change from baseline of IIEF scores. The difference between TT and placebo was 2.70 (95% CI 1.40, 4.01) for the ITT population. A statistically significant difference between TT and placebo was found for Intercourse Satisfaction (p=0.0005), Orgasmic Function (p=0.0325), Sexual Desire (p=0.0038), Overall Satisfaction (p=0.0028) as well as in GEQ responses (p<0.0001), in favour of TT. There were no differences in the incidence of adverse events (AEs) between the two groups and the therapy was well tolerated. There were no drug-related serious AEs. Following the 12-week treatment period, significant improvement in sexual function was observed with TT compared with placebo in men with mild to moderate ED. TT was generally well tolerated for the treatment of ED.
Keywords
Erectile dysfunction; Randomized controlled trial; Tribulus terrestris.
Copyright © 2017 Elsevier B.V. All rights reserved.
| PMID: | 28364864 |
|---|---|
| DOI: | 10.1016/j.maturitas.2017.01.011 |
| Category: | Men's Health / Prostate |
The best supplements with Tribulus Terrestris in Men's Health / Prostate category:
- Spark Herbal Aphrodisiac CBD Capsules - 20 capsules/400 mg total CBD (Plants Not Pills) - Herbal aphrodisiac capsules with 20mg of organically-grown, THC-free CBD extract in each capsule. It contains among others: Tribulus Terrestris.
- Sports, Tribulus, 1,000 mg, 180 Tablets (Now Foods) - Tribulus Extract (Tribulus Terrestris) has been used for centuries in ancient Greece, India and Africa to enhance vitality and virility. It contains among others: Tribulus Terrestris.
- TestoJack 200, 120 Veg Capsules (Now Foods) - NOW TestoJack 200 is a combination of natural herbal ingredients known to support a man's healthy sexual activity and overall vitality. It contains among others: Tribulus Terrestris.
Articles similar to "Evaluation of the Efficacy and Safety of Tribulus Terrestris in Male Sexual dysfunction-A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial."
- The role of Tribulus Terrestris in Men's Health / Prostate: Tribulus Terrestris Versus Placebo in the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms in Patients With Late-Onset Hypogonadism: A Placebo-Controlled Study. (Aging is associated with a series of morphological and functional modifications that leads to reduced physiological efficiency and atrophy of various organs and systems...)
- The impact of Tribulus Terrestris on Men's Health / Prostate: The Effect of Tribulus Terrestris Extract on Motility and Viability of Human Sperms After Cryopreservation. ( Semen cryopreservation produces significant amounts of reactive oxygen species (ROS), which may lead to impairment of sperm morphology, function, and ultimately, male fertility... The present study demonstrated that the protective effects of Tribulus terrestris, which improves human sperm motility and viability, may be due to its antioxidant properties. On the basis of the results, the researchers concluded that Tribulus terrestris can be used as a safe therapeutic alternative to current modalities for the management of motility dysfunction in males. )